Loading chat...
MA H4892
Bill
Status
1/8/2026
Primary Sponsor
Joint Committee on Financial Services
Click for details
AI Summary
-
Prohibits health insurance carriers and utilization review organizations from imposing prior authorization, step therapy, or other protocols that restrict or delay FDA-approved drugs for serious mental illness
-
Applies the same restrictions to MassHealth (Medicaid) and its contracted managed care entities
-
Defines "serious mental illness" to include 8 conditions: bipolar disorders, childhood/adolescent depression, major depressive disorders, obsessive-compulsive disorders, paranoid personality and psychotic disorders, schizo-affective disorders, schizophrenia, and PTSD
-
Amends both Chapter 176O (private insurance regulation) and Chapter 118E (MassHealth) of the General Laws
Legislative Description
Preserving access to treatment for patients with serious mental illnesses
Last Action
Reported favorably by committee and referred to the Joint Committee on Health Care Financing
1/8/2026